Clinical, Conventional CT and Radiomic Feature-Based Machine Learning Models for Predicting ALK Rearrangement Status in Lung Adenocarcinoma Patients
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical, Conventional CT and Radiomic Feature-Based Machine Learning Models for Predicting ALK Rearrangement Status in Lung Adenocarcinoma Patients
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-03-20
DOI
10.3389/fonc.2020.00369
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Predicting EGFR Mutation Status in Lung Adenocarcinoma on CT Image Using Deep Learning
- (2019) Shuo Wang et al. EUROPEAN RESPIRATORY JOURNAL
- Clinicopathological Features of ALK Expression in 9889 Cases of Non-small-Cell Lung Cancer and Genomic Rearrangements Identified by Capture-Based Next-Generation Sequencing: A Chinese Retrospective Analysis
- (2019) Ruiying Zhao et al. Molecular Diagnosis & Therapy
- Radiomics signature: A potential and incremental predictor for EGFR mutation status in NSCLC patients, comparison with CT morphology
- (2019) Wenting Tu et al. LUNG CANCER
- ALK Resistance Mutations and Efficacy of Lorlatinib in Advanced Anaplastic Lymphoma Kinase-Positive Non–Small-Cell Lung Cancer
- (2019) Alice T. Shaw et al. JOURNAL OF CLINICAL ONCOLOGY
- CT Imaging Characteristics of Non-Small Cell Lung Cancer with Anaplastic Lymphoma Kinase (ALK) Rearrangements: A Systematic Review and Meta-analysis
- (2019) Dexter P. Mendoza et al. Clinical Lung Cancer
- Long-term follow-up of persistent pulmonary pure ground-glass nodules with deep learning–assisted nodule segmentation
- (2019) Lin-Lin Qi et al. EUROPEAN RADIOLOGY
- Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology
- (2018) Neal I. Lindeman et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Applicability of a prognostic CT-based radiomic signature model trained on stage I-III non-small cell lung cancer in stage IV non-small cell lung cancer
- (2018) Evelyn E.C. de Jong et al. LUNG CANCER
- Heterogeneity in Lung Cancer
- (2018) Vitor Manuel Leitão de Sousa et al. PATHOBIOLOGY
- Crizotinib versus Chemotherapy in Asian Patients with ALK-Positive Advanced Non-small Cell Lung Cancer
- (2018) Makoto Nishio et al. Cancer Research and Treatment
- Targeted Therapy With Anaplastic Lymphoma Kinase Inhibitor (Alectinib) in Adolescent Metastatic Non–Small Cell Lung Carcinoma
- (2018) Sharjeel Usmani et al. CLINICAL NUCLEAR MEDICINE
- CT-based radiomics signature for differentiating solitary granulomatous nodules from solid lung adenocarcinoma
- (2018) Xinguan Yang et al. LUNG CANCER
- Peritumoral radiomics features predict distant metastasis in locally advanced NSCLC
- (2018) Tai H. Dou et al. PLoS One
- Value of 18F–FDG PET/CT for predicting EGFR mutations and positive ALK expression in patients with non-small cell lung cancer: a retrospective analysis of 849 Chinese patients
- (2017) Zhilei Lv et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Associations between radiologist-defined semantic and automatically computed radiomic features in non-small cell lung cancer
- (2017) Stephen S. F. Yip et al. Scientific Reports
- Radiologic Characteristics of Surgically Resected Non-Small Cell Lung Cancer With ALK Rearrangement or EGFR Mutations
- (2016) Tae Jung Kim et al. ANNALS OF THORACIC SURGERY
- Clinical and CT characteristics of surgically resected lung adenocarcinomas harboring ALK rearrangements or EGFR mutations
- (2016) Hua Wang et al. EUROPEAN JOURNAL OF RADIOLOGY
- Imaging Characteristics in ALK Fusion-Positive Lung Adenocarcinomas by Using HRCT
- (2015) Takeo Nakada et al. Annals of Thoracic and Cardiovascular Surgery
- Role of Imaging Biomarkers in Predicting Anaplastic Lymphoma Kinase–Positive Lung Adenocarcinoma
- (2015) Chae Jin Jeong et al. CLINICAL NUCLEAR MEDICINE
- Comparative analysis of clinicoradiologic characteristics of lung adenocarcinomas with ALK rearrangements or EGFR mutations
- (2015) J. Y. Zhou et al. EUROPEAN RADIOLOGY
- CT Radiogenomic Characterization of EGFR, K-RAS, and ALK Mutations in Non-Small Cell Lung Cancer
- (2015) Stefania Rizzo et al. EUROPEAN RADIOLOGY
- Intratumoral Heterogeneity of ALK-Rearranged and ALK/EGFR Coaltered Lung Adenocarcinoma
- (2015) Weijing Cai et al. JOURNAL OF CLINICAL ONCOLOGY
- Decoding Tumor Phenotypes for ALK, ROS1, and RET Fusions in Lung Adenocarcinoma Using a Radiomics Approach
- (2015) Hyun Jung Yoon et al. MEDICINE
- Intratumor Heterogeneity of ALK-Rearrangements and Homogeneity of EGFR-Mutations in Mixed Lung Adenocarcinoma
- (2015) Federica Zito Marino et al. PLoS One
- Advanced Adenocarcinoma of the Lung: Comparison of CT Characteristics of Patients with Anaplastic Lymphoma Kinase Gene Rearrangement and Those with Epidermal Growth Factor Receptor Mutation
- (2015) Chang-Min Choi et al. RADIOLOGY
- Are there imaging characteristics associated with lung adenocarcinomas harboring ALK rearrangements?
- (2014) Darragh F. Halpenny et al. LUNG CANCER
- ALKMolecular Phenotype in Non–Small Cell Lung Cancer: CT Radiogenomic Characterization
- (2014) Shota Yamamoto et al. RADIOLOGY
- Anaplastic lymphoma kinase gene rearrangements in patients with advanced-stage non-small-cell lung cancer: CT characteristics and response to chemotherapy
- (2013) Jangchul Park et al. Cancer Medicine
- Epidemiology of Lung Cancer
- (2013) Carole Ridge et al. SEMINARS IN INTERVENTIONAL RADIOLOGY
- Clinicoradiologic characteristics of patients with lung adenocarcinoma harboring EML4-ALK fusion oncogene
- (2012) Takayuki Fukui et al. LUNG CANCER
- Metabolic and metastatic characteristics of ALK-rearranged lung adenocarcinoma on FDG PET/CT
- (2012) Hongyoon Choi et al. LUNG CANCER
- International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
- (2011) William D. Travis et al. Journal of Thoracic Oncology
- Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis
- (2011) Alice T Shaw et al. LANCET ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More